新生病原性CSF1R变体涉及微质功能障碍在发烧性感染相关综合征的发病因子
Kristen S Fisher1, Jesse M Levine1, Alexander Ankar1
1Division of Neurology and Developmental Neuroscience, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, Texas, USA.
Epilepsia
|September 16, 2025
概括
一种罕见的综合症,发烧性感染相关综合症 (FIRES),可能源于微质调节中的遗传缺陷. 发现了一种新型的CSF1R基因变异,这表明FIRES病原体中的微质功能障碍.
科学领域:
- 神经免疫学 神经免疫学
- 遗传学 是一个遗传学.
- 发病学 (Epileptology) 是一个专业的学科.
背景情况:
- 发烧性感染相关综合征 (FIRES) 是一种严重的神经系统疾病,其特征是耐火状态和发烧性疾病后的.
- 虽然免疫调节失调有关,但FIRES的潜在遗传原因在很大程度上仍未确定.
- 在大多数情况下,没有确定FIRES的单一基因.
研究的目的:
- 为了研究FIRES的遗传基础.
- 确定可能导致FIRES病变的潜在遗传变异.
- 探索微质功能障碍在FIRES中的作用.
主要方法:
- 在FIRES患者身上进行了临床全基因组测序.
- 用分子建模来评估已识别的变体对蛋白质结构和功能的影响.
- 进行了功能性测试,以评估变异对CSF1R信号传递的影响.
主要成果:
- 在一个患有FIRES的患者中,在CSF1R基因中发现了一种预测的破坏性误解变异.
- 分子建模表明,该变体破坏了CSF1受体的ATP结合域的稳定.
- 功能性研究证实该变种破坏了CSF1R自酸化,从而确定了其致病性.
结论:
- 这种情况表明微质功能障碍在FIRES的发病过程中发挥了作用,由CSF1R变体介导.
- 这些发现有助于理解FIRES病因中的先天性免疫失调.
- 向微质细胞可能是FIRES患者的潜在治疗策略.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
831
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
831
Cystic Fibrosis: Pathogenesis
726
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
726
Epilepsy and Seizures: Overview
1.2K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.2K


